TY - JOUR
T1 - REST, a master transcriptional regulator in neurodegenerative disease
AU - Hwang, Jee Yeon
AU - Zukin, R. Suzanne
N1 - Funding Information:
This work was supported by National Institutes of Health grant NS46742, HD083828, and MH092877, and the generous grant from the F.M. Kirby Foundation to RSZ, AHA Scientist Development Grant 16SDG31500001 and NARSAD Young Investigator Grant 25369 to JYH. RSZ is the F. M. Kirby Professor in Neural Repair and Protection.
Publisher Copyright:
© 2017 The Authors
PY - 2018/2
Y1 - 2018/2
N2 - The restrictive element-1 silencing transcription factor)/NRSF (neuron-restrictive silencing factor (NRSF) is a transcriptional repressor which acts via epigenetic remodeling to silence target genes. Emerging evidence indicates that REST is a master transcriptional regulator of neuron-specific genes not only in neurogenesis and neuronal differentiation, but also in differentiated neurons during the critical period in postnatal brain development, where it plays a role in fine-tuning of genes involved in synaptic plasticity, and in normal aging, where it promotes neuroprotection by repressing genes involved in oxidative stress and β-amyloid toxicity. This review focuses on recent findings that dysregulation of REST and REST-dependent epigenetic remodeling provide a central mechanism critical to the progressive neurodegeneration associated with neurologic disorders and diseases including global ischemia, stroke, epilepsy, Alzheimer's and Huntington's disease.
AB - The restrictive element-1 silencing transcription factor)/NRSF (neuron-restrictive silencing factor (NRSF) is a transcriptional repressor which acts via epigenetic remodeling to silence target genes. Emerging evidence indicates that REST is a master transcriptional regulator of neuron-specific genes not only in neurogenesis and neuronal differentiation, but also in differentiated neurons during the critical period in postnatal brain development, where it plays a role in fine-tuning of genes involved in synaptic plasticity, and in normal aging, where it promotes neuroprotection by repressing genes involved in oxidative stress and β-amyloid toxicity. This review focuses on recent findings that dysregulation of REST and REST-dependent epigenetic remodeling provide a central mechanism critical to the progressive neurodegeneration associated with neurologic disorders and diseases including global ischemia, stroke, epilepsy, Alzheimer's and Huntington's disease.
UR - http://www.scopus.com/inward/record.url?scp=85041697425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041697425&partnerID=8YFLogxK
U2 - 10.1016/j.conb.2017.12.008
DO - 10.1016/j.conb.2017.12.008
M3 - Review article
C2 - 29351877
AN - SCOPUS:85041697425
SN - 0959-4388
VL - 48
SP - 193
EP - 200
JO - Current Opinion in Neurobiology
JF - Current Opinion in Neurobiology
ER -